GuruTrack
GILD

GILD

GILEAD SCIENCES INC

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
GILEAD SCIENCES INC (GILD) is held by 9 tracked hedge-fund managers, a combined reported value of ~$1.68B; the largest are Ken Griffin, Renaissance Technologies, Ken Griffin. This quarter: 1 new, 3 added, 2 trimmed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Heating up
Gurus holding9
Congress trades20
Price$130.86vs quarter-end-6.11%
Sectors2
This quarter's moves
New1
Added3
Trimmed / sold2
Top holderKen Griffin
Renaissance TechnologiesTrim
Value $300.00M0.5% of portfolio2,152,5282026 Q1
Ken GriffinCALL—
Value $206.43M— of portfolio1,481,2002026 Q1
Dan LoebBig add
Value $112.65M2.1% of portfolio1,500,0002013 Q4
Izzy EnglanderCALL—
Value $87.13M— of portfolio625,2002026 Q1
Ken GriffinPUT—
Value $83.66M— of portfolio600,3002026 Q1
Izzy EnglanderPUT—
Value $80.01M— of portfolio574,1002026 Q1
Steven CohenCALL—
Value $6.79M— of portfolio48,7002026 Q1
Steven CohenPUT—
Value $1.73M— of portfolio12,4002026 Q1
Dan LoebCALL—
Value $257.0K— of portfolio128,0002013 Q2

Insider Trading

Officers · directors · Form 4

  • Andrew D Dickinson

    Chief Financial Officer

    Sell$389.8K
    3,000 @ $129.93Traded 2026-07-15Filed 2026-07-16

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$389.8K
    3,000 @ $129.92Traded 2026-07-15Filed 2026-07-16

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$393.9K
    3,100 @ $127.08Traded 2026-07-01Filed 2026-07-02

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$1.50M
    11,900 @ $126.09Traded 2026-07-01Filed 2026-07-02

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$56.4K
    450 @ $125.40Traded 2026-06-15Filed 2026-06-16

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$182.7K
    1,480 @ $123.42Traded 2026-06-15Filed 2026-06-16

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$132.7K
    1,070 @ $124.00Traded 2026-06-15Filed 2026-06-16

  • Andrew D Dickinson

    Chief Financial Officer

    Sell$376.2K
    3,000 @ $125.40Traded 2026-06-15Filed 2026-06-16

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Buy
    2,796Traded 2026-06-10Filed 2026-06-11

  • Wettan Keeley M Cain

    EVP Gen Counsel, Legal & Comp

    Buy
    589Traded 2026-06-10Filed 2026-06-11

  • Andrew D Dickinson

    Chief Financial Officer

    Sell$162.9K
    1,341 @ $121.48Traded 2026-06-10Filed 2026-06-11

  • Andrew D Dickinson

    Chief Financial Officer

    Buy
    2,796Traded 2026-06-10Filed 2026-06-11

  • Dietmar Berger

    Chief Medical Officer

    Sell$31.9K
    263 @ $121.48Traded 2026-06-10Filed 2026-06-11

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$511.8K
    4,213 @ $121.48Traded 2026-06-10Filed 2026-06-11

  • O'Day Daniel Patrick

    Chairman & CEO

    Buy
    8,779Traded 2026-06-10Filed 2026-06-11

  • Wettan Keeley M Cain

    EVP Gen Counsel, Legal & Comp

    Sell$34.4K
    283 @ $121.48Traded 2026-06-10Filed 2026-06-11

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$162.9K
    1,341 @ $121.48Traded 2026-06-10Filed 2026-06-11

  • Dietmar Berger

    Chief Medical Officer

    Buy
    533Traded 2026-06-10Filed 2026-06-11

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$404.8K
    3,062 @ $132.22Traded 2026-06-01Filed 2026-06-02

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$1.43M
    10,900 @ $131.10Traded 2026-06-01Filed 2026-06-02

  • O'Day Daniel Patrick

    Chairman & CEO

    Sell$138.0K
    1,038 @ $132.97Traded 2026-06-01Filed 2026-06-02

  • GILEAD SCIENCES, INC.

    10% Owner

    Buy$12.50M
    471,698 @ $26.50Traded 2026-05-26Filed 2026-05-27

  • Johanna Mercier

    Chief Comm & Corp Aff Officer

    Sell$1.01M
    7,749 @ $130.29Traded 2026-05-15Filed 2026-05-18

  • Andrew D Dickinson

    Chief Financial Officer

    Sell$396.8K
    3,000 @ $132.27Traded 2026-05-15Filed 2026-05-18

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.